TB Online is no longer maintained. This is an archive of the site. For news on TB please go to:
https://globaltbcab.org/MTBVAC will move to Phase 2 trials in 2018
TuBerculosis Vaccine Initiative (TBVI)
Oct. 25, 2017, 3:44 p.m.
The new Spanish TB vaccine MTBVAC has received 12 million euros to carry out Phase 2a trials in new-borns and in adults in South Africa.
To read the press release, click here.